Related Experiment Video
Updated: Dec 10, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Practical considerations of utilizing propensity score methods in clinical development using real-world and
Qing Li1, Jianchang Lin1, Andy Chi1
1Statistical and Quantitative Sciences, Takeda Pharmaceuticals, 300 Massachusetts Ave, Cambridge, MA 02139, United States.
Real-World Data (RWD) and Real-World Evidence (RWE) offer significant opportunities in drug development. This paper details rigorous statistical methods, particularly propensity score methods, for analyzing RWD effectively in clinical trials.
Area of Science:
- Pharmacovigilance and Drug Development
- Biostatistics and Epidemiology
- Real-World Data Analytics
Background:
- The increasing availability of Real-World Data (RWD) and Real-World Evidence (RWE) presents new opportunities for drug clinical development and lifecycle management.
- RWD and RWE can enhance clinical trial design, planning, and execution, serving as complements or substitutes for traditional trials.
- Rigorous statistical methodologies are crucial for ensuring the robustness and reliability of analyses using RWD.
Purpose of the Study:
- To provide a systematic review and discussion of propensity score methods for the rigorous application of RWD in clinical development.
- To introduce commonly used and emerging propensity score methods, detailing their advantages and disadvantages.
- To illustrate practical considerations for utilizing propensity score methods through case studies.
Main Methods:
- Review of statistical methodologies for analyzing RWD, with a focus on propensity score methods.
- Discussion of propensity score methods, including their pros and cons.
- Presentation of three case studies demonstrating the practical application of propensity score methods in study design and evaluation using RWD and historical data.
Main Results:
- Propensity score methods are widely used for analyzing non-randomized trials with indirect comparisons.
- The paper discusses practical considerations for utilizing propensity score methods in clinical development.
- Case studies illustrate the application of these methods in real-world and historical data analysis.
Conclusions:
- Effective utilization of RWD and RWE in clinical development necessitates robust statistical methodologies like propensity score methods.
- A systematic approach, including careful consideration of patient populations, endpoints, covariates, and sensitivity analyses, is essential for successful implementation.
- This paper aims to fill the gap in systematic reviews concerning the practical application of propensity score methods in clinical development.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Analysis of Population Pharmacokinetic Data
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview